WESTMONT PHARMACEUTICALS INC., } IPC No. 14-2014-00061 Opposer, } Opposition to: } Appln. Serial No. 4-2013-00001758 } Date Filed: 18 February 2013 -versus- } TM: "ANGIMAX" } } } CATHAY YSS DISTRIBUTORS CO. INC., } Respondent- Applicant. } )(-------------------------------------------------------------------)( NOTICE OF DECISION OCHAVE & ESCALONA Counsel for the Opposer No. 66 United Street Mandaluyong City JIMENEZ GONZALES BELLO VALDEZ CALUYA & FERNANDEZ Counsel for Respondent-Applicant 5 th Floor, SOL Building 112 Amorsolo Street, Legaspi Village Makati City GREETINGS: Please be informed that Decision No. 2016 - ..J::Q_ dated February 18, 2016 (copy enclosed) was promulgated in the above entitled case. Taguig City, February 18, 2016. For the Director: ~o.~9' Atty. EDWIN DANILO A. DATll'l§; Director Ill Bureau of Legal Affairs Republic of the Philippines INTELLECTUAL PROPERTY OFFICE Intellectual Property Center # 28 Upper McKinley Road, McKinley Hill Town Center, Fort Bonifacio, Taguig City 1634 Philippines ewww.ipophil.gov.ph T: +632-2386300 • F: +632-5539480 •
[email protected] < • I l. WESTMONT PHARMACEUTICALS IPC No. 14-2014-00061 INC., Opposition to: Opposer, Appln. No. 4-2013-00001758 - versus - Date Filed: 18 February 2013 Trademark: "ANGIMAX" CATHAY YSS DISTRIBUTORS CO. INC., Respondent-Applicant. Decision No. 2016 - ..S'O x --------------------------------------------- x DECISION WESTMONT PHARMACEUTICALS INC. ("Opposer"), 1 filed an oppos1tion to Trademark Application Serial No. 4-2013-00001758. The application, filed by CATHAY YSS DISTRIBUTORS 2 3 CO. INC. ("Respondent-Applicant") , covers the mark "ANGIMAX" for use on goods under class 05 namely: pharmaceutical preparations namely tablet for treatment for ischaemic heart disease, angina pectoris, sequelae of infraction. The Opposer alleges the following among other things: "7. The mark 'ANGIMAX' filed by Respondent-Applicant so resembles the trademark 'AMPIMAX' owned by Opposer and duly registered with the IPO prior to the publication for opposition of the mark 'ANG IMAX'.